UBS AM’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.62M | Buy |
161,565
+51,656
| +47% | +$2.76M | ﹤0.01% | 1436 |
|
|
2025
Q1 | $4.45M | Buy |
109,909
+38,458
| +54% | +$1.56M | ﹤0.01% | 1633 |
|
|
2024
Q4 | $1.99M | Buy |
71,451
+11,035
| +18% | +$307K | ﹤0.01% | 2047 |
|
|
2024
Q3 | $1.73M | Sell |
60,416
-5,198
| -8% | -$149K | ﹤0.01% | 2120 |
|
|
2024
Q2 | $1.54M | Buy |
65,614
+19,075
| +41% | +$448K | ﹤0.01% | 2139 |
|
|
2024
Q1 | $1.18M | Hold |
46,539
| – | – | ﹤0.01% | 1929 |
|
|
2023
Q4 | $1.09M | Hold |
46,539
| – | – | ﹤0.01% | 1980 |
|
|
2023
Q3 | $2.35M | Buy |
46,539
+8,449
| +22% | +$427K | ﹤0.01% | 1539 |
|
|
2023
Q2 | $1.46M | Hold |
38,090
| – | – | ﹤0.01% | 1826 |
|
|
2023
Q1 | $1.46M | Buy |
38,090
+2,121
| +6% | +$81.1K | ﹤0.01% | 1826 |
|
|
2022
Q4 | $1.97M | Buy |
35,969
+11,360
| +46% | +$623K | ﹤0.01% | 1532 |
|
|
2022
Q3 | $838K | Sell |
24,609
-9,263
| -27% | -$315K | ﹤0.01% | 2071 |
|
|
2022
Q2 | $320K | Buy |
33,872
+15,232
| +82% | +$144K | ﹤0.01% | 2461 |
|
|
2022
Q1 | $265K | Buy |
+18,640
| New | +$265K | ﹤0.01% | 2625 |
|
|
2021
Q2 | – | Sell |
-7,300
| Closed | -$212K | – | 2752 |
|
|
2021
Q1 | $212K | Sell |
7,300
-1,100
| -13% | -$31.9K | ﹤0.01% | 2559 |
|
|
2020
Q4 | $217K | Hold |
8,400
| – | – | ﹤0.01% | 2481 |
|
|
2020
Q3 | $259K | Buy |
+8,400
| New | +$259K | ﹤0.01% | 2339 |
|